Clinical Trial Update: Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery [NA]

View source ↗

Summary

This clinical trial update notes the completion of a trial evaluating chemoembolization with doxorubicin for unresectable liver cancer, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: Yale University | Conditions: Liver Cancer | NA | Status: COMPLETED | Results posted: 2018-07-18